58 related articles for article (PubMed ID: 26567569)
1. Regulation of cyclooxygenase 2 expression by agonists of PPAR nuclear receptors in the model of endotoxin tolerance in astrocytes.
Astakhova AA; Chistyakov DV; Pankevich EV; Sergeeva MG
Biochemistry (Mosc); 2015 Oct; 80(10):1262-70. PubMed ID: 26567569
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
3. PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells.
Sergeeva MG; Aleshin SE; Grabeklis S; Reiser G
J Neurochem; 2010 Oct; 115(2):399-410. PubMed ID: 20670373
[TBL] [Abstract][Full Text] [Related]
4. Regulation of peroxisome proliferator-activated receptor β/δ expression and activity levels by toll-like receptor agonists and MAP kinase inhibitors in rat astrocytes.
Chistyakov DV; Aleshin S; Sergeeva MG; Reiser G
J Neurochem; 2014 Aug; 130(4):563-74. PubMed ID: 24806616
[TBL] [Abstract][Full Text] [Related]
5. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
[TBL] [Abstract][Full Text] [Related]
6. Antiinflammatory Effect of Rosiglitazone via Modulation of mRNA Stability of Interleukin 10 and Cyclooxygenase 2 in Astrocytes.
Pankevich EV; Astakhova AA; Chistyakov DV; Sergeeva MG
Biochemistry (Mosc); 2017 Nov; 82(11):1276-1284. PubMed ID: 29223154
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy.
Khoo NK; Hebbar S; Zhao W; Moore SA; Domann FE; Robbins ME
Redox Biol; 2013; 1(1):70-9. PubMed ID: 24024139
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) protects against ceramide-induced cellular toxicity in rat brain astrocytes and neurons by activation of ceramide kinase.
Aleshin S; Reiser G
Mol Cell Neurosci; 2014 Mar; 59():127-34. PubMed ID: 24513118
[TBL] [Abstract][Full Text] [Related]
10. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice.
Richardson TA; Morgan ET
J Pharmacol Exp Ther; 2005 Aug; 314(2):703-9. PubMed ID: 15860574
[TBL] [Abstract][Full Text] [Related]
11. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
[TBL] [Abstract][Full Text] [Related]
12. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
14. PPAR activators and COX inhibitors selectively block cytokine-induced COX-2 expression and activity in human aortic smooth muscle cells.
Rival Y; Puech L; Taillandier T; Benéteau N; Rouquette A; Lestienne F; Dupont-Passelaigue E; Le Roy I; Patoiseau JF; Junquéro D
Eur J Pharmacol; 2009 Mar; 606(1-3):121-9. PubMed ID: 19374865
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
[TBL] [Abstract][Full Text] [Related]
16. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro.
Cerciat M; Unkila M; Garcia-Segura LM; Arevalo MA
Glia; 2010 Jan; 58(1):93-102. PubMed ID: 19533603
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B.
Huang L; Guan T; Qian Y; Huang M; Tang X; Li Y; Sun H
Eur J Pharmacol; 2011 Dec; 672(1-3):169-74. PubMed ID: 21970807
[TBL] [Abstract][Full Text] [Related]
19. Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes.
Beyan H; Goodier MR; Nawroly NS; Hawa MI; Bustin SA; Ogunkolade WB; Londei M; Yousaf N; Leslie RD
Diabetes; 2006 Dec; 55(12):3439-45. PubMed ID: 17130490
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
